Spots Global Cancer Trial Database for Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Official Title: Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With Levofloxacin as Prophylaxis for Bacterial Infections in Immunocompromised Patients After Allogeneic Transplantation of Hematopoietic Stem Cells
Study ID: NCT00215007
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Charite, CBF, Berlin, , Germany
Contact Details
Name: Igor Wolfgang Blau, Dr.
Affiliation: Charite, CBF, Berlin, Germany
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
